期刊
EUROPACE
卷 23, 期 5, 页码 665-673出版社
OXFORD UNIV PRESS
DOI: 10.1093/europace/euaa287
关键词
Atrial fibrillation; Atrial high rate episodes; Burden; Duration; Stroke; Systemic embolism
Atrial fibrillation (AF) burden may exhibit a biological gradient with stroke risk, suggesting that different levels of AF burden could impact the risk of stroke in patients. Combining AF burden assessment with clinical risk scoring can help refine the assessment of stroke risk in AF patients.
Atrial fibrillation (AF) is an established independent risk factor for stroke. Current guidelines regard AF as binary; either present or absent, with the decision for anti-coagulation driven by clinical variables alone. However, there are increasing data to support a biological gradient of AF burden and stroke risk, both in clinical and non-clinical AF phenotypes. As such, this raises the concept of combining AF burden assessment with a clinical risk score to refine and individualize the assessment of stroke risk in AF-the CHA(2)DS(2)VASc-AFBurden score. We review the published data supporting a biological gradient to try and construct a putative schema of risk attributable to AF burden.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据